Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report

BACKGROUND: There is no established treatment after failure of proven therapies for patients with metastatic renal cell carcinoma. CASE PRESENTATION: A 66-year-old Japanese man with metastatic renal cell carcinoma became refractory to interferon α and sunitinib therapies. He started treatment with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Masaki, Ikeda, Yohei, Hasegawa, Go, Nakagawa, Yuki, Nishiyama, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475964/
https://www.ncbi.nlm.nih.gov/pubmed/31006385
http://dx.doi.org/10.1186/s13256-019-2041-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475964/
https://www.ncbi.nlm.nih.gov/pubmed/31006385
http://dx.doi.org/10.1186/s13256-019-2041-8

Ejemplares similares